Spark Biopharma

Spark Biopharma was founded in 2016. The new technology platform developed through the CRI Center for Chemical Proteomics has been transformed into a real drug research and development process, providing new solutions to improve human health. SPARK BIOPHARMA, Inc. envisions that a fundamental understanding of human diseases at the molecular level can be achieved by integrating biology, chemistry, proteomics, and informatics, helping to create a new foundation or generate first-class small molecule therapies.